EXICURE, INC. Repayments of Long-Term Debt
EXICURE, INC. (XCUR) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2024-06-06
- EXICURE, INC. repayments of long-term debt for the quarter ending 2023-12-31 was $0.00.
- EXICURE, INC. repayments of long-term debt for the quarter ending 2023-09-30 was $0.00.
- EXICURE, INC. repayments of long-term debt for the quarter ending 2023-06-30 was $0.00.
- EXICURE, INC. repayments of long-term debt for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. repayments of long-term debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- EXICURE, INC. repayments of long-term debt for fiscal 2022 was $7.50M, a 25.00% decline from fiscal 2021.
- EXICURE, INC. repayments of long-term debt for fiscal 2021 was $10.00M, a 100.04% increase from fiscal 2020.
- EXICURE, INC. repayments of long-term debt for fiscal 2020 was $5.00M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 10-K · filed 2024-06-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 10-Q · filed 2024-05-16 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | $0.00 10-Q/A · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2023-03-31 | $0.00 10-Q/A · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $7.50M 10-K · filed 2024-06-06 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $7.50M 10-Q · filed 2024-05-16 | $17.50M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | $7.50M 10-Q/A · filed 2024-06-06 | $17.50M derived: sum of 3 quarters · filed 2024-06-06 | $17.50M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | $7.50M 10-Q/A · filed 2024-06-06 | $17.50M derived: sum of 2 quarters · filed 2024-06-06 | $17.50M derived: sum of 3 quarters · filed 2024-06-06 | $17.50M derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $10.00M derived: sum of 2 quarters · filed 2023-03-27 | $10.00M derived: sum of 3 quarters · filed 2023-03-27 | $10.00M 10-K · filed 2023-03-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 3 quarters · filed 2022-08-15 | $0.00 derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $0.00 derived: sum of 3 quarters · filed 2022-05-16 | $0.00 derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $0.00 derived: sum of 2 quarters · filed 2022-03-25 | $0.00 derived: sum of 3 quarters · filed 2022-03-25 | $5.00M 10-K · filed 2022-03-25 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $0.00 derived: sum of 2 quarters · filed 2021-11-19 | $5.00M 10-Q · filed 2021-11-19 | $5.00M derived: sum of 4 quarters · filed 2021-11-19 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.00M 10-Q · filed 2021-08-12 | $5.00M derived: sum of 3 quarters · filed 2021-08-12 | $5.00M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $5.00M 10-Q · filed 2021-05-12 | $5.00M derived: sum of 2 quarters · filed 2021-05-12 | $5.00M derived: sum of 3 quarters · filed 2021-05-12 | $5.00M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $0.00 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | $0.00 derived: sum of 3 quarters · filed 2020-08-12 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $0.00 10-K/A · filed 2019-09-23 | ||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 | |||
| 2017-12-31 | $406.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $1.00M 10-K/A · filed 2019-09-23 | ||
| 2017-09-30 | $595.00K 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 10-K · filed 2018-03-09 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |